Skip to content

Clinical trials

Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Country / region: Malaysia Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20111
20131
20151
20172
20212
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting2
Unknown status2
No longer available1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals8
Gruppo Italiano Malattie EMatologiche dell'Adulto1
Ministry of Health, Malaysia1
UCSI University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive11
Leukemia3
Myeloproliferative Disorders3
Philadelphia Chromosome3
Bone Marrow Diseases2
Blast Crisis1
Bronchiolitis Obliterans Syndrome1
Hematologic Diseases1
Hematologic Neoplasms1
Leukemia, Myeloid1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.